428 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 9 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
GJB1Gap junction protein beta 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GJB2Gap junction protein beta 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
MitochondriaTissue enriched
GJB3Gap junction protein beta 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Vesicles
Cell Junctions
Tissue enhanced
GJC1Gap junction protein gamma 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoli
Cell Junctions
Cytosol
Tissue enhanced
GJC3Gap junction protein gamma 3Predicted membrane proteins
Transporters
Tissue enhanced
GJD4Gap junction protein delta 4Predicted membrane proteins
Transporters
Tissue enhanced
GLE1GLE1, RNA export mediatorDisease related genes
Potential drug targets
Predicted intracellular proteins
Transporters
Nuclear membrane
Nucleoli
Expressed in all
GLRA1Glycine receptor alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
GLRA3Glycine receptor alpha 3FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
GLRBGlycine receptor betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GNLYGranulysinPredicted intracellular proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRIA2Glutamate ionotropic receptor AMPA type subunit 2Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GRIA3Glutamate ionotropic receptor AMPA type subunit 3Disease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRIK4Glutamate ionotropic receptor kainate type subunit 4Predicted membrane proteins
Transporters
Tissue enhanced
GRIN1Glutamate ionotropic receptor NMDA type subunit 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
Tissue enriched
GRIN2CGlutamate ionotropic receptor NMDA type subunit 2CFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
GSDMAGasdermin APredicted intracellular proteins
Transporters
Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol
Tissue enriched
GSDMBGasdermin BPredicted intracellular proteins
Transporters
Tissue enhanced
GSDMCGasdermin CPredicted intracellular proteins
Transporters
MitochondriaTissue enhanced
GSDMDGasdermin DPredicted intracellular proteins
Transporters
NucleoplasmExpressed in all
HBA1Hemoglobin subunit alpha 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBA2Hemoglobin subunit alpha 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBBHemoglobin subunit betaDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
HCN2Hyperpolarization activated cyclic nucleotide gated potassium channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
HCN4Hyperpolarization activated cyclic nucleotide gated potassium channel 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
HTN3Histatin 3Predicted secreted proteins
Transporters
VesiclesTissue enriched
HTR3A5-hydroxytryptamine receptor 3AFDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HTR3D5-hydroxytryptamine receptor 3DFDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
HVCN1Hydrogen voltage gated channel 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
IPO11Importin 11Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Transporters
Nucleus
Nucleoli fibrillar center
Expressed in all
IPO13Importin 13Predicted intracellular proteins
Transporters
Expressed in all
IPO4Importin 4Predicted intracellular proteins
Transporters
CytosolTissue enhanced
IPO5Importin 5Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
IPO7Importin 7Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
IPO8Importin 8Predicted intracellular proteins
Transporters
NucleusExpressed in all
IPO9Importin 9Predicted intracellular proteins
Predicted secreted proteins
Transporters
Vesicles
Cytosol
Expressed in all
ITPR1Inositol 1,4,5-trisphosphate receptor type 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
KCNA2Potassium voltage-gated channel subfamily A member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel subfamily A member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium voltage-gated channel modifier subfamily F member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNH1Potassium voltage-gated channel subfamily H member 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium voltage-gated channel subfamily H member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
« prev | Page of 9 | next »